| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.026 | 0.9 |